Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors (Q34515995)

2 August 2017

1 reference

title

Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors (English)

1 reference

2 August 2017

0 references

1 reference

1 reference

1 reference

G Thomas Strickland

1

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

2 August 2017

1 reference

2 August 2017

volume

43

1 reference

2 August 2017

issue

5

1 reference

2 August 2017

page(s)

915-922

1 reference

Changing pattern of schistosomiasis in Egypt 1935--79

2 August 2017

cites work

1 reference

7 January 2021

The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt

1 reference

7 January 2021

The epidemiology of schistosomiasis in Egypt: summary findings in nine governorates

1 reference

7 January 2021

The epidemiology of schistosomiasis in Egypt: Fayoum Governorate.

1 reference

7 January 2021

Characteristic sonographic pattern of schistosomal hepatic fibrosis.

1 reference

7 January 2021

Grading of hepatic schistosomiasis by the use of ultrasonography

1 reference

7 January 2021

Drugs for the control of parasitic diseases: current status and development in schistosomiasis

1 reference

7 January 2021

High seroprevalence of hepatitis C infection among risk groups in Egypt.

1 reference

7 January 2021

Hepatitis C antibody prevalence in blood donors in different governorates in Egypt

1 reference

7 January 2021

Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence

1 reference

7 January 2021

Response of hepatitis C genotype-4 naïve patients to 24 weeks of Peg-interferon-alpha2b/ribavirin or induction-dose interferon-alpha2b/ribavirin/amantadine: a non-randomized controlled study

1 reference

7 January 2021

Peginterferon {alpha}-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response.

1 reference

7 January 2021

Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity

1 reference

7 January 2021

Hepatitis c in a community in Upper Egypt: risk factors for infection.

1 reference

7 January 2021

Estimation of the risk of transmission of hepatitis C between spouses in Egypt based on seroprevalence data

1 reference

7 January 2021

Intrafamilial transmission of hepatitis C in Egypt

1 reference

7 January 2021

High prevalence of hepatitis C in Egyptian patients with chronic liver disease

1 reference

7 January 2021

Role of hepatitis C infection in chronic liver disease in Egypt.

1 reference

7 January 2021

Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections

1 reference

7 January 2021

The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients

1 reference

7 January 2021

Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt.

1 reference

7 January 2021

Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States

1 reference

7 January 2021

Case-control study of non-Hodgkin's lymphoma and hepatitis C virus infection in Egypt

1 reference

7 January 2021

Gastrointestinal manifestations of schistosomiasis

1 reference

7 January 2021

The relationship between uncomplicated schistosomiasis and hepatitis B infection

1 reference

7 January 2021

The Impact of Endemic Schistosomiasis on Acute Viral Hepatitis

1 reference

7 January 2021

Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni

1 reference

7 January 2021

Interferon therapy in patients with chronic hepatitis C and schistosomiasis

1 reference

7 January 2021

Helminth infection results in decreased virus-specific CD8 cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance

1 reference

7 January 2021

Increased susceptibility of mice infected with Schistosoma mansoni to recombinant vaccinia virus: association of viral persistence with egg granuloma formation

1 reference

7 January 2021

Analysis of successful immune responses in persons infected with hepatitis C virus

1 reference

7 January 2021

Determinants of viral clearance and persistence during acute hepatitis C virus infection

1 reference

7 January 2021

Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4( ) T-cell and cytokine response.

1 reference

7 January 2021

Specific cellular immune response and cytokine patterns in patients coinfected with hepatitis C virus and Schistosoma mansoni.

1 reference

7 January 2021

Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4 T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis.

1 reference

7 January 2021

Schistosoma infection inhibits cellular immune responses to core HCV peptides.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21173

1 reference

2 August 2017

1 reference